pre-exposure prophylaxis

[키워드] 95% CI Admission age baseline characteristics clinical presentation Comorbidities condition Control control subject control subjects controls coronavirus disease COVID-19 COVID-19 in patient demographics diabete disease dosages failure groups HCQ HCQ therapy hospital Hospitalization hospitalized patient Hydroxychloroquine in-hospital mortality individual IQR less Logistic regression Lupus mechanical ventilation median age medications New York City obesity objective outcome Patient pre-exposure prophylaxis Prednisone Prevalence preventive proportion pulmonary disease receive receiving reported Result rheumatic disease rheumatoid arthritis rheumatologic diseases severe complication statistically significant difference subject with COVID-19
[DOI] 10.1093/rap/rkab014 PMC 바로가기 [Article Type] Concise Report